In this article, we aimed to summarize the current knowledge on the epidemiology, pathophysiology and management of new-onset perioperative and postoperative AF (POAF) in non-cardiothoracic surgery and provide a practical approach for anesthesiologists and non-cardiologist clinicians.
Various findings such as age, hypertension, diabetes mellitus, cardiac risk factor, on preoperative electrocardiogram premature beats, left anterior fascicular block or left ventricular hypertrophy pose a higher risk for POAF.
The first thing to do in patients with POAF is to determine the underlying cause of this arrhythmia. In most cases, identifying and eliminating the triggering cause will suffice. On the other hand, hemodynamic data should be evaluated. The primary goal of treatment in patients with life-threatening symptoms is to maintain hemodynamic stability. Deterioration of hemodynamic stability and development of shock with AF with high ventricular rate is a condition that requires immediate cardioversion. Hemodynamically stable patients with POAF should receive rate control therapy with increasing dose with continuous cardiac monitoring to a heart rate
Key words: Keywords: atrial fibrillation, anesthesia, non-cardiothoracic surgery
|
